South & Central America Coagulation Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von Willebrand\'s Disease, and Others), Type [Clinical Laboratory Analyzers (Controls & Calibrators, Assays & Reagents, Instruments/Systems, Coagulation Factors, and Others) and Point-of-Care Testing Analyzers], Offering [Diagnosis (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimmer Testing, Platelets Function Testing, and Others) and Treatment (Anti-Fibrinolytic Drugs, Birth Control Pills, Desmopressin & Immunosuppressive Medicines, Vitamin K Supplements, Blood Thinners, Thrombin Inhibitors or Thrombolytics, Replacement Therapy, Catheter-Assisted Thrombus Removal, and Others)], Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Others), and End User (Clinical Laboratories, Hospitals, and Others)

No. of Pages: 95    |    Report Code: BMIRE00029858    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Coagulation Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. South & Central America Coagulation Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. South & Central America Coagulation Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Prevalence of Blood Disorders
  • 5.1.2 Rising Incidence of Cardiovascular Diseases
5.2 Market Opportunities
  • 5.2.1 Growing Organic and Inorganic Strategies by Key Market Players
5.3 Future Trends
  • 5.3.1 Development of Point-of-Care (POC) Coagulation Analyzers
5.4 Impact of Drivers and Restraints

6. South & Central America Coagulation Market Regional Analysis

6.1 South & Central America Coagulation Market Overview
6.2 South & Central America Coagulation Market Revenue 2020-2030 (US$ Million)
6.3 South & Central America Coagulation Market Forecast Analysis

7. South & Central America Coagulation Market Analysis – by Disease Indications

7.1 Vitamin K Deficiency
  • 7.1.1 Overview
  • 7.1.2 Vitamin K Deficiency: South & Central America Coagulation Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Liver Disease
  • 7.2.1 Overview
  • 7.2.2 Liver Disease: South & Central America Coagulation Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Disseminated Intravascular Coagulation & Pulmonary Embolism
  • 7.3.1 Overview
  • 7.3.2 Disseminated Intravascular Coagulation & Pulmonary Embolism: South & Central America Coagulation Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Development of Circulating Anticoagulants
  • 7.4.1 Overview
  • 7.4.2 Development of Circulating Anticoagulants: South & Central America Coagulation Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Hemophilia
  • 7.5.1 Overview
  • 7.5.2 Hemophilia: South & Central America Coagulation Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Von Willebrand\'s Disease
  • 7.6.1 Overview
  • 7.6.2 Von Willebrand\'s Disease: South & Central America Coagulation Market – Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Coagulation Market Analysis – by Type

8.1 Clinical Laboratory Analyzers
  • 8.1.1 Overview
  • 8.1.2 Clinical Laboratory Analyzers: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Point-of-Care Testing Analyzers
  • 8.2.1 Overview
  • 8.2.2 Point-of-Care Testing Analyzers: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Coagulation Market Analysis – by Offering

9.1 Prothrombin Time Testing
  • 9.1.1 Overview
  • 9.1.2 Point-of-Care Testing Analyzers: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Fibrinogen Testing
  • 9.2.1 Overview
  • 9.2.2 Point-of-Care Testing Analyzers: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Activated Clotting Time Testing
  • 9.3.1 Overview
  • 9.3.2 Point-of-Care Testing Analyzers: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Activated Partial Thromboplastin Time Testing
  • 9.4.1 Overview
  • 9.4.2 Point-of-Care Testing Analyzers: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.5 D-Dimmer Testing
  • 9.5.1 Overview
  • 9.5.2 Point-of-Care Testing Analyzers: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Platelets Function Testing
  • 9.6.1 Overview
  • 9.6.2 Point-of-Care Testing Analyzers: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Coagulation Market – South and Central America Analysis

10.1 South and Central America
  • 10.1.1 South & Central America Coagulation Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 South & Central America Coagulation Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 Brazil: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 Brazil: South & Central America Coagulation Market Breakdown, by Disease Indications
    • 10.1.1.1.2 Brazil: South & Central America Coagulation Market Breakdown, by Type
    • 10.1.1.1.3 Brazil: South & Central America Coagulation Market Breakdown, by Offering
  • 10.1.1.2 Argentina: South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Argentina: South & Central America Coagulation Market Breakdown, by Disease Indications
    • 10.1.1.2.2 Argentina: South & Central America Coagulation Market Breakdown, by Type
    • 10.1.1.2.3 Argentina: South & Central America Coagulation Market Breakdown, by Offering
  • 10.1.1.3 Rest of South and Central America : South & Central America Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Rest of South and Central America : South & Central America Coagulation Market Breakdown, by Disease Indications
    • 10.1.1.3.2 Rest of South and Central America : South & Central America Coagulation Market Breakdown, by Type
    • 10.1.1.3.3 Rest of South and Central America : South & Central America Coagulation Market Breakdown, by Offering

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. South & Central America Coagulation Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 F. Hoffmann-La Roche Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Genrui Biotech Co., Ltd
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Horiba Ltd.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 ImproGen Diagnostik Kimya San. & Tic. Ltd.ti
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Siemens Healthineers AG
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Sysmex Corp
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Transasia Bio-Medicals Ltd
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - South & Central America Coagulation Market

1. F. Hoffmann-La Roche Ltd

 

2. Genrui Biotech Co., Ltd

3. Horiba Ltd.

4. ImproGen Diagnostik Kimya San. & Tic. Ltd.?ti

5. Siemens Healthineers AG

6. Sysmex Corp

7. Transasia Bio-Medicals Ltd

 

 

 

 

 

south-and-central-america-coagulation-market